Sherbrooke Park Advisers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,540
Closed -$399K 242
2025
Q3
$399K Sell
2,540
-3,719
-59% -$574K 0.19% 228
2025
Q2
$1.05M Buy
+6,259
New +$929K 0.46% 35
2024
Q4
Sell
-16,532
Closed -$1.83M 802
2024
Q3
$1.83M Buy
16,532
+2,105
+15% +$220K 0.42% 12
2024
Q2
$1.42M Buy
14,427
+2,209
+18% +$225K 0.25% 93
2024
Q1
$1.37M Sell
12,218
-10,157
-45% -$1.1M 0.27% 86
2023
Q4
$2.26M Buy
22,375
+16,070
+255% +$1.59M 1.06% 2
2023
Q3
$547K Sell
6,305
-3,495
-36% -$316K 0.17% 219
2023
Q2
$927K Buy
9,800
+5,500
+128% +$465K 0.49% 50
2023
Q1
$325K Sell
4,300
-5,700
-57% -$430K 0.49% 88
2022
Q4
$769K Buy
+10,000
New +$760K 0.56% 44

Other funds holding CAH

Sherbrooke Park Advisers's CAH Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 2,540 shares — an estimated $399K sold.

Sherbrooke Park Advisers first reported a position in CAH in Q4 2022 and held it in 10 quarters. The position peaked at $2.26M in Q4 2023. 1,407 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 2,540 Cardinal Health shares in Q4 2025, an estimated $399K.
  • Sherbrooke Park Advisers first reported a position in Cardinal Health in Q4 2022 and held it in 10 quarters.
  • Sherbrooke Park Advisers's Cardinal Health position peaked at $2.26M in Q4 2023.
  • 1,407 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.